Top-Tier Journal Recognition (IF=56.1): Cloud-Clone C3a Antibody Aids New Anti-Tumor Immune Axis Discovery inCancer Cell
PD-1 Blockade Triggers HBV-Specific B-Cell Responses to Unlock New Combination Immunotherapy Directions for HBV-Associated Hepatocellular Carcinoma HUSTON, TX, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- Cancer Cell (Impact Factor = …